Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ETX-636 in Advanced Solid Tumors and Breast Cancer
NCT06993844Phase 2Recruiting
- Sponsor
- ENSEM Therapeutics
- Start
- Jun 2025
- Primary completion
- Jun 2027
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of ETX-636 in solid tumor, breast cancer, sponsored by ENSEM Therapeutics. Started Jun 2025; status: recruiting.
02
Drugs
ETX-636
03
Conditions
solid tumorbreast cancer
Beyond the preview
Go deeper on NCT06993844.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06993844.